- The Effect of Second-Generation Antipsychotics Administration for 1-Year on the Platelet Activities in Patients With Schizophrenia: Retrospective Study
-
Oh YS, Lee JW, Oh HS, Kim SJ, Im WY, Lee NH, Kim JW
- KMID: 2538662
- Korean J Psychosom Med.
- 2022 Dec;30(2):165-171.
- doi: 10.22722/KJPM.2022.30.2.165
Objectives：This study was conducted to investigate the effect of 1-year administration of second-generation antipsychotics (SGAs) on the platelet activity in patients with schizophrenia through a retrospective review of the medical... -
- CITED
-
- Close
- SHARE
-
- Close
- History and Future of Antipsychotic Drugs
-
Yi JS
- KMID: 2439022
- J Korean Neuropsychiatr Assoc.
- 2019 Feb;58(1):2-11.
- doi: 10.4306/jknpa.2019.58.1.2
After the discovery of antipsychotic drugs, the nature of clinical practice entered a period of inexorable transition. The advances of psychopharmacotherapy have interacted in complex ways with clinical practice, and... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparative Efficacy and Safety of Long-acting Injectable and Oral Second-generation Antipsychotics for the Treatment of Schizophrenia: A Systematic Review and Meta-analysis
-
Park SC, Choi MY, Choi J, Park E, Tchoe HJ, Suh JK, Kim YH, Won SH, Chung YC, Bae KY, Lee SK, Park CM, Lee SH
- KMID: 2428965
- Clin Psychopharmacol Neurosci.
- 2018 Nov;16(4):361-375.
- doi: 10.9758/cpn.2018.16.4.361
We aimed to compare the efficacy and safety of long-acting injectable (LAI) and oral second-generation antipsychotics (SGAs) in treating schizophrenia by performing a systematic review and meta-analysis. MEDLINE, EMBASE, PsycINFO,... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-Term Evolution of Metabolic Status in Patients with Schizophrenia Stably Maintained on Second-Generation Antipsychotics
-
Jeong SH, Lee NY, Kim SH, Chung IW, Youn T, Kang UG, Ahn YM, You HY, Kim YS
- KMID: 2428888
- Psychiatry Investig.
- 2018 Jun;15(6):628-637.
- doi: 10.30773/pi.2018.01.18.1
OBJECTIVE: Second-generation antipsychotics (SGAs) increase the risk of metabolic syndrome (MetS). Despite the risk of MetS, SGAs may have to be continued with change in some patients. The aim of... -
- CITED
-
- Close
- SHARE
-
- Close
- Arterial Stiffness in Patients Taking Second-generation Antipsychotics
-
Fındıklı E, Gökçe M, Nacitarhan V, Camkurt MA, Fındıklı HA, Kardaş S, Sahin MC, Karaaslan
- KMID: 2356161
- Clin Psychopharmacol Neurosci.
- 2016 Nov;14(4):365-370.
- doi: 10.9758/cpn.2016.14.4.365
OBJECTIVE: That treatment with second-generation antipsychotics (SGAs) causes metabolic side effects and atherosclerosis in patients with schizophrenia and bipolar disorder (BD) is well-known. Increased arterial stiffness is an important marker... -
- CITED
-
- Close
- SHARE
-
- Close
- Simultaneous Comparison of Efficacy and Tolerability of Second-Generation Antipsychotics in Schizophrenia: Mixed-Treatment Comparison Analysis Based on Head-to-Head Trial Data
-
Oh GH, Yu JC, Choi KS, Joo EJ, Jeong SH
- KMID: 2316388
- Psychiatry Investig.
- 2015 Jan;12(1):46-54.
- doi: 10.4306/pi.2015.12.1.46
OBJECTIVE: Second-generation antipsychotics have been repeatedly shown to be superior to placebo. However, the comparative efficacy among these drugs has not been systematically evaluated. In this study, we used Mixed... -
- CITED
-
- Close
- SHARE
-
- Close
- Trends in Scientific Literature on Atypical Antipsychotics in South Korea: A Bibliometric Study
-
Lopez-Munoz F, Shen WW, Pae CU, Moreno R, Rubio G, Molina JD, Noriega C, Perez-Nieto MA, Huelves L, Alamo C
- KMID: 2316240
- Psychiatry Investig.
- 2013 Mar;10(1):8-16.
OBJECTIVE: We have carried out a bibliometric study on the scientific publications in relation to atypical or second-generation antipsychotic drugs (SGAs) in South Korea. METHODS: With the EMBASE and MEDLINE databases,... -
- CITED
-
- Close
- SHARE
-
- Close
